414 related articles for article (PubMed ID: 25629638)
1. Modified Masaoka stage and size are independent prognostic predictors in thymoma and modified Masaoka stage is superior to histopathologic classifications.
Roden AC; Yi ES; Jenkins SM; Edwards KK; Donovan JL; Cassivi SD; Marks RS; Garces YI; Aubry MC
J Thorac Oncol; 2015 Apr; 10(4):691-700. PubMed ID: 25629638
[TBL] [Abstract][Full Text] [Related]
2. Reproducibility of 3 histologic classifications and 3 staging systems for thymic epithelial neoplasms and its effect on prognosis.
Roden AC; Yi ES; Jenkins SM; Edwards KK; Donovan JL; Lewis JE; Cassivi SD; Marks RS; Garces YI; Aubry MC
Am J Surg Pathol; 2015 Apr; 39(4):427-41. PubMed ID: 25634747
[TBL] [Abstract][Full Text] [Related]
3. Thymoma: inter-relationships among World Health Organization histology, Masaoka staging and myasthenia gravis and their independent prognostic significance: a single-centre experience.
Ruffini E; Filosso PL; Mossetti C; Bruna MC; Novero D; Lista P; Casadio C; Oliaro A
Eur J Cardiothorac Surg; 2011 Jul; 40(1):146-53. PubMed ID: 21093283
[TBL] [Abstract][Full Text] [Related]
4. [Histologic subtyping and prognosis of thymoma: a study of 108 cases].
Jiao X; Yin HL; Lu ZF; Zhao YC; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):445-9. PubMed ID: 19035114
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and clinical relevance of the World Health Organization schema for the classification of thymic epithelial tumors: a clinicopathologic study of 108 patients and literature review.
Kim DJ; Yang WI; Choi SS; Kim KD; Chung KY
Chest; 2005 Mar; 127(3):755-61. PubMed ID: 15764754
[TBL] [Abstract][Full Text] [Related]
6. World Health Organization histologic classification: an independent prognostic factor in resected thymomas.
Rena O; Papalia E; Maggi G; Oliaro A; Ruffini E; Filosso P; Mancuso M; Novero D; Casadio C
Lung Cancer; 2005 Oct; 50(1):59-66. PubMed ID: 16009453
[TBL] [Abstract][Full Text] [Related]
7. Thymoma. Histologic subclassification is an independent prognostic factor.
Quintanilla-Martinez L; Wilkins EW; Choi N; Efird J; Hug E; Harris NL
Cancer; 1994 Jul; 74(2):606-17. PubMed ID: 8033040
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted magnetic resonance imaging of thymoma: ability of the Apparent Diffusion Coefficient in predicting the World Health Organization (WHO) classification and the Masaoka-Koga staging system and its prognostic significance on disease-free survival.
Priola AM; Priola SM; Giraudo MT; Gned D; Fornari A; Ferrero B; Ducco L; Veltri A
Eur Radiol; 2016 Jul; 26(7):2126-38. PubMed ID: 26427698
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for the reporting of surgically resected thymic epithelial tumors.
Weydert JA; De Young BR; Leslie KO;
Hum Pathol; 2009 Jul; 40(7):918-23. PubMed ID: 19524103
[TBL] [Abstract][Full Text] [Related]
10. Masaoka staging is of prognostic relevance in type B3 / C thymomas.
Luebke T; Beckurts KT; Wickenhauser C; Schneider P; Hoelscher AH; Moenig SP
Anticancer Res; 2004; 24(6):4113-9. PubMed ID: 15736461
[TBL] [Abstract][Full Text] [Related]
11. WHO histologic classification is a prognostic indicator in thymoma.
Kondo K; Yoshizawa K; Tsuyuguchi M; Kimura S; Sumitomo M; Morita J; Miyoshi T; Sakiyama S; Mukai K; Monden Y
Ann Thorac Surg; 2004 Apr; 77(4):1183-8. PubMed ID: 15063231
[TBL] [Abstract][Full Text] [Related]
12. The major prognostic factors of thymomas: about a Tunisian study of 100 cases.
Mlika M; Boudaya MS; Laabidi S; Zaimi Y; Smadhi H; Marghli A; El Mezni F; Kilani T
Pathologica; 2015 Mar; 107(1):9-13. PubMed ID: 26591625
[TBL] [Abstract][Full Text] [Related]
13. Thymic epithelial tumors: a clinicopathologic study of 249 cases from a single institution.
Su XY; Wu WL; Liu N; Zhang SF; Li GD
Int J Clin Exp Pathol; 2014; 7(11):7760-7. PubMed ID: 25550813
[TBL] [Abstract][Full Text] [Related]
14. Long-term disease-free survival of patients with radically resected thymomas: relevance of cell-cycle protein expression.
Mineo TC; Ambrogi V; Mineo D; Baldi A
Cancer; 2005 Nov; 104(10):2063-71. PubMed ID: 16206298
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification.
Park MS; Chung KY; Kim KD; Yang WI; Chung JH; Kim YS; Chang J; Kim JH; Kim SK; Kim SK
Ann Thorac Surg; 2004 Sep; 78(3):992-7; discussion 997-8. PubMed ID: 15337034
[TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of Masaoka and Müller-Hermelink classification in patients with thymic tumors.
Lardinois D; Rechsteiner R; Läng RH; Gugger M; Betticher D; von Briel C; Krueger T; Ris HB
Ann Thorac Surg; 2000 May; 69(5):1550-5. PubMed ID: 10881840
[TBL] [Abstract][Full Text] [Related]
17. Type B thymoma: is prognosis predicted only by World Health Organization classification?
Kim HK; Choi YS; Kim J; Shim YM; Han J; Kim K
J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1431-1435.e1. PubMed ID: 20038470
[TBL] [Abstract][Full Text] [Related]
18. Outcome of multimodality treatment for 188 cases of type B3 thymoma.
Gao L; Wang C; Fang W; Zhang J; Lv C; Fu S
J Thorac Oncol; 2013 Oct; 8(10):1329-34. PubMed ID: 24457243
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival and prognostic factors in thymic epithelial tumours.
Rea F; Marulli G; Girardi R; Bortolotti L; Favaretto A; Galligioni A; Sartori F
Eur J Cardiothorac Surg; 2004 Aug; 26(2):412-8. PubMed ID: 15296907
[TBL] [Abstract][Full Text] [Related]
20. Multimodality therapy for locally advanced thymomas: A propensity score-matched cohort study from the European Society of Thoracic Surgeons Database.
Leuzzi G; Rocco G; Ruffini E; Sperduti I; Detterbeck F; Weder W; Venuta F; Van Raemdonck D; Thomas P; Facciolo F;
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):47-57.e1. PubMed ID: 26403869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]